Received May 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | 2 | FDP00015 | IM / RA |
The treatment was the second of a two-series vaccination. The outcome was uneventful, with no symptoms or signs of reaction reported.
None reported
AIDS (acquired immunodeficiency syndrome), CD4 <=200 Hormone replacement therapy (HRT) Preventative health care Vitreous degeneration Brugada syndrome, type 2, noted on EKG 9/12/17 Chronic viral hepatitis B without the delta agent and coma Vitamin D deficiency Abnormal anal Papanicolaou smear Methamphetamine abuse in remission History of syphilis
bictegrav-emtricit-tenofov (BIKTARVY) 50-200-25 mg tab estradiol (ESTRACE) 2 mg tab darunavir-cobicistat (PREZCOBIX) 800-150 mg-mg tablet tablet spironolactone (ALDACTONE) 50 mg tablet cholecalciferol, VITAMIN D3, 50 mcg (2,000 unit)
NKDA
N/A